Drugs / IN-M00007
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT07311811 | Jan → Mar 2026 overdue | — | HK inno.N Corporation | Not yet recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | IN-M00007 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07311811 ↗ |
| Route | Oral | “after a single oral dose administration of IN-M00007 and IN-R00007 in healthy adult volunteers” NCT07311811 ↗ |